{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:30:25Z","timestamp":1781879425721,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jfo.2013.01.012","type":"journal-article","created":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T08:45:16Z","timestamp":1376642716000},"page":"740-747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["RGTA-based matrix therapy in severe experimental corneal lesions: Safety and efficacy studies"],"prefix":"10.1016","volume":"36","author":[{"given":"F.","family":"Brignole-Baudouin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Warnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Barritault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2013.01.012_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0039-6257(00)00200-9","article-title":"The pathology of dry eye","volume":"45","author":"Baudouin","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2013.01.012_bib0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0181-5512(07)89584-2","article-title":"Une nouvelle approche pour une meilleure compr\u00e9hension des maladies de la surface oculaire","volume":"30","author":"Baudouin","year":"2007","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2013.01.012_bib0015","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2004.10.042","article-title":"Allergic conjunctivitis: update on pathophysiology and prospects for future treatment","volume":"115","author":"Ono","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jfo.2013.01.012_bib0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1350-9462(99)00007-5","article-title":"Growth factors: importance in wound healing and maintenance of transparency of the cornea","volume":"19","author":"Imanishi","year":"2000","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jfo.2013.01.012_bib0025","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1542-0124(12)70613-4","article-title":"Growth factors in the tear film: role in tissue maintenance, wound healing, and ocular pathology","volume":"5","author":"Klenkler","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jfo.2013.01.012_bib0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00417-004-0955-2","article-title":"Efficacy of topical nerve growth factor treatment in dogs affected by dry eye","volume":"243","author":"Coassin","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2013.01.012_bib0035","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1167\/iovs.05-1205","article-title":"Promotion of corneal epithelial wound healing by a tetrapeptide (SSSR) derived from IGF-1","volume":"47","author":"Yamada","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2013.01.012_bib0040","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.exer.2006.03.010","article-title":"Nerve growth factor effect on human primary fibroblastic-keratocytes: possible mechanism during corneal healing","volume":"83","author":"Micera","year":"2006","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jfo.2013.01.012_bib0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1463-5224.2006.00439.x","article-title":"Efficacy of two chondroitin sulfate ophthalmic solutions in the therapy of spontaneous chronic corneal epithelial defects and ulcerative keratitis associated with bullous keratopathy in dogs","volume":"9","author":"Ledbetter","year":"2006","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.jfo.2013.01.012_bib0050","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1167\/iovs.04-0775","article-title":"Sensitizing effect of substance P on corneal epithelial migration induced by IGF-1, fibronectin, or interleukin-6","volume":"46","author":"Yamada","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2013.01.012_bib0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000092626","article-title":"The use of nerve growth factor in surgical wound healing of the cornea","volume":"38","author":"Cellini","year":"2006","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jfo.2013.01.012_bib0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/01.ico.0000176609.42838.df","article-title":"Use of nerve growth factor to treat congenital neurotrophic corneal ulceration","volume":"25","author":"Tan","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2013.01.012_bib0065","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/BF01880673","article-title":"Fibroblast growth factor 2, heparin and suramin reduce epithelial ulcer development in experimental HSV-1 keratitis","volume":"235","author":"Rieck","year":"1997","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2013.01.012_bib0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10792-007-9180-4","article-title":"Regression of severe corneal stromal neovascularization with topical cyclosporine 0.05% after penetrating keratoplasty for fungal corneal ulcer","volume":"29","author":"Sonmez","year":"2009","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2013.01.012_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1100\/2012\/194848","article-title":"An overview on dry eye treatment: approaches for cyclosporin a delivery","volume":"194848","author":"Yavuz","year":"2012","journal-title":"Sci World J"},{"key":"10.1016\/j.jfo.2013.01.012_bib0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.iio.0000212135.77675.6a","article-title":"Topical cyclosporine for treatment of ocular surface disease","volume":"46","author":"Foulks","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.jfo.2013.01.012_bib0085","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajo.2004.08.040","article-title":"The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study","volume":"139","author":"Kojima","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2013.01.012_bib0090","first-page":"167","article-title":"Transplantation of amniotic membrane in corneal ulcers and persistant epithelial defects","volume":"35","author":"Grzeti\u0107-Lenac","year":"2011","journal-title":"Coll Antropol"},{"key":"10.1016\/j.jfo.2013.01.012_bib0095","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0181-5512(06)73902-X","article-title":"Avantages de la transplantation de membrane amniotique pour les maladies de la surface oculaire","volume":"29","author":"Muraine","year":"2006","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2013.01.012_bib0100","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1167\/iovs.04-0495","article-title":"Immunosuppressive factors secreted by human amniotic epithelial cells","volume":"46","author":"Li","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2013.01.012_bib0105","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/jbm.a.30723","article-title":"Heparin-like synthetic polymers, named RGTAs, mimic biological effects of heparin in vitro","volume":"78","author":"Rouet","year":"2006","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.jfo.2013.01.012_bib0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0003-4509(06)75306-8","article-title":"Les agents de r\u00e9g\u00e9n\u00e9ration (ou RGTAs): une nouvelle approche th\u00e9rapeutique","volume":"64","author":"Barritault","year":"2006","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.jfo.2013.01.012_bib0115","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/jcp.1041500126","article-title":"Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF","volume":"150","author":"Tardieu","year":"1992","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jfo.2013.01.012_bib0120","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1096\/fj.00-0756com","article-title":"Heparan mimetic regulates collagen expression and TGF-b1 distribution in gamma-irradiated human intestinal smooth muscle cells","volume":"15","author":"Alexakis","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.jfo.2013.01.012_bib0125","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/(SICI)1097-4636(199811)42:2<286::AID-JBM14>3.0.CO;2-H","article-title":"Chemically modified dextrans modulate expression of collagen phenotype by cultured smooth muscle cells in relation to the degree of carboximethyl, benzamide, and sulfatation substitutions","volume":"42","author":"Mestries","year":"1998","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.jfo.2013.01.012_bib0130","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1163\/156856206776986305","article-title":"Dextran derivatives modulate collagen matrix organization in dermal equivalent","volume":"17","author":"Frank","year":"2006","journal-title":"J Biomater Sci Polym Ed."},{"key":"10.1016\/j.jfo.2013.01.012_bib0135","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jbm.a.32124","article-title":"Matrix therapy in regenerative medicine, a new approach to chronic wound healing","volume":"90","author":"Barbier-Chassefi\u00e8re","year":"2009","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.jfo.2013.01.012_bib0140","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/glycob\/cwg082","article-title":"Improved and simple microassay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies","volume":"13","author":"Barbosa","year":"2003","journal-title":"Glycobiology"},{"key":"10.1016\/j.jfo.2013.01.012_bib0145","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1074\/jbc.M000837200","article-title":"Human plasmin enzymatic activity is inhibited by chemically modified dextrans","volume":"275","author":"Ledoux","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jfo.2013.01.012_bib0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0141-8130(95)01074-2","article-title":"FGF protection and inhibition of human neutrophil elastase by carboxylmethyl benzylamide sulfonate dextran derivates","volume":"18","author":"Meddahi","year":"1996","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jfo.2013.01.012_bib0155","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/jbm.a.30880","article-title":"Periodontitis destructions are restored by synthetic glycosaminoglycan mimetic","volume":"79A","author":"Lallam-Laroye","year":"2006","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.jfo.2013.01.012_bib0160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jbm.a.30874","article-title":"RGTA OTR4120, a heparan sulfate mimetic, is a possible long-term active agent to heal burned skin","volume":"80A","author":"Garcia-Filipe","year":"2007","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.jfo.2013.01.012_bib0165","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/PRS.0b013e318200a910","article-title":"Matrix therapy with RGTA OTR4120 improves healing time and quality in hairless rats with deep second-degree burns","volume":"127","author":"Zakine","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jfo.2013.01.012_bib0170","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/8756-3282(95)00402-5","article-title":"Heparan-like molecules induce the repair of skull defects","volume":"17","author":"Blanquaert","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.jfo.2013.01.012_bib0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00001665-199601000-00007","article-title":"Modulation of cranial bone healing with a heparin-like dextran derivated","volume":"7","author":"Albo","year":"1996","journal-title":"J Craniofac Surg"},{"key":"10.1016\/j.jfo.2013.01.012_bib0180","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jbm.1293","article-title":"Heparin-like polymer improved healing of gastric and colic ulceration","volume":"60","author":"Meddahi","year":"2002","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.jfo.2013.01.012_bib0185","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jbm.10283","article-title":"Pharmacological studies of RGTA(11), a heparan sulfate mimetic polymer, efficient on muscle regeneration","volume":"62","author":"Meddahi","year":"2002","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.jfo.2013.01.012_bib0190","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1021\/ma048485p","article-title":"Non degradative sulfation of polysaccharides. Synthesis and structure characterization of biologically active heparan sulfate mimetics","volume":"38","author":"Papy-Garcia","year":"2005","journal-title":"Macromolecules"},{"key":"10.1016\/j.jfo.2013.01.012_bib0195","article-title":"Management of herpes zoster neurotrophic ulcer using a new matrix therapy agent (RGTA): a case report","volume":"35","author":"De Monchy","year":"2012","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2013.01.012_bib0200","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0181-5512(08)72462-8","article-title":"\u00c9tude pilote sur un nouvel agent de th\u00e9rapie matricielle (RGTA OTR4120) pour le traitement d\u2019ulc\u00e8res corn\u00e9ens et de dystrophies corn\u00e9ennes r\u00e9sistant aux traitements","volume":"31","author":"Chebbi","year":"2008","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2013.01.012_bib0205","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3565(25)08751-8","article-title":"Method for the study of irritation and toxicity of substances applied topically to the skin and mucous membrane","volume":"82","author":"Draize","year":"1944","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jfo.2013.01.012_bib0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-5793(03)00064-4","article-title":"Heparin-like dextran derivates as well as glycosaminoglycans inhibit the enzymatic activity of human cathepsin G","volume":"537","author":"Ledoux","year":"2003","journal-title":"FEBS"},{"key":"10.1016\/j.jfo.2013.01.012_bib0215","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1096\/fj.02-0708com","article-title":"A new approach to treat tissue destruction in periodontitis with chemically modified dextran polymers","volume":"17","author":"Escartin","year":"2003","journal-title":"J FASEB"},{"key":"10.1016\/j.jfo.2013.01.012_bib0220","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0304-3940(95)12182-X","article-title":"Influence of a dextran derivative on myosin heavy chain expression during rat skeletal muscle regeneration","volume":"201","author":"Aamari","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jfo.2013.01.012_bib0225","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jbm.a.10400","article-title":"RGTA modulates the healing pattern of a defect in a monolayer of osteoblastic cells by acting on both proliferation and migration","volume":"64A","author":"Blanquaert","year":"2003","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/j.jfo.2013.01.012_bib0230","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000267497","article-title":"CMDBS, functional analogue of heparin sulphate as a new class of corneal ulcer healing agents","volume":"26","author":"Fredj-Reygrobellet","year":"1994","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jfo.2013.01.012_bib0235","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1524-475X.2009.00548.x","article-title":"Stimulated neovascularization, inflammation resolution and collagen maturation in healing rat cutaneous wounds by a heparan sulfate glycosaminoglycan mimetic, OTR4120","volume":"17","author":"Tong","year":"2009","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jfo.2013.01.012_bib0240","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.exphem.2009.06.005","article-title":"Glycosaminoglycan mimetics-induced mobilization of hematopoietic progenitors and stem cells into mouse peripheral blood: structure\/function insights","volume":"37","author":"Albanese","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jfo.2013.01.012_bib0245","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.scr.2011.09.005","article-title":"Glycosaminoglycans mimetics potentiate the clonogenicity, proliferation, migration and differentiation properties of rat mesenchymal stem cells","volume":"8","author":"Frescaline","year":"2012","journal-title":"Stem Cell Res"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551213002404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551213002404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:03:50Z","timestamp":1759259030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551213002404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0181551213002404"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2013.01.012","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RGTA-based matrix therapy in severe experimental corneal lesions: Safety and efficacy studies","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2013.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}